Skip to content

ANI-guided Intraoperative Analgesia vs Conventional Intraoperative Analgesia

Effects of Analgesia Nociception Index (ANI)-Guided Intraoperative Analgesia on Postoperative Pain: a Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04877574
Enrollment
170
Registered
2021-05-07
Start date
2021-07-01
Completion date
2022-07-15
Last updated
2022-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Postoperative Pain, Surgery

Brief summary

This study evaluates the effects of Analgesia Nociception Index (ANI)-guided intraoperative analgesia on postoperative pain in patients undergoing open gynecologic surgery.

Detailed description

Postoperative pain is one of the most common postoperative complications and is significantly associated with patient's quality of recovery. Analgesia Nociception Index (ANI) is known to analyze the high frequency component of heart rate variability in relation to respiratory frequency, providing the objective information on the degree of pain. However, most previous studies conducted by using ANI were observational studies or small-sized randomized controlled studies. In the present study, the investigators aimed to evaluate the effects of ANI-guided intraoperative analgesia on moderate-to-severe postoperative pain by performing randomized controlled study.

Interventions

PROCEDUREANI-guided intraoperative analgesia

Intraoperative analgesia is performed by controlling the effect-site concentration of remifentanil to maintain 50-70 of ANI.

PROCEDUREConventional intraoperative analgesia

Intraoperative analgesia is performed by controlling the effect-site concentration of remifentanil at the discretion of attending anesthesiologists based on hemodynamic parameters.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 * Elective open gynecological surgery * American Society of Anaesthesiologists physical status classification 1-3

Exclusion criteria

* Laparoscopic surgery or robot-assisted surgery * Patients who had analgesic agents, anti-psychotic agents, anticonvulsants which were related to chronic pain * Patients who had hypersensitivity to analgesic agents or medications related anesthesia. * Patients who were required to have mechanical ventilation after surgery * Patients who had arrhythmia * Patients who transferred to the surgical intensive care unit immediately after surgery * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
the incidence of moderate-to-severe postoperative painduring 1 hour of stay in the postanesthesia care unitthe incidence of moderate-to-severe postoperative pain is defined as a case in which pain with numeric rating scale (NRS) of 5 or more is reported during stays in the postanesthesia care unit. Pain assessment is performed two times during stays in the postanesthesia care unit.

Secondary

MeasureTime frameDescription
the amount of intraoperative remifentanilintraoperativethe amount of intraoperative remifentanil used during anesthesia
Quality of Recovery-15 (QoR-15) scoreat postoperative 24 hourQoR-15 questionnaire is recorded by an investigator. QoR-15 questionnaire has minimum score of 0 and maximum score of 150, and higher score indicates the better quality of recovery.
the incidence of postoperative nausea and vomitingat postoperative 1 hour, 24 hour, 72 hourthe incidence of postoperative nausea and vomiting is recorded by an investigator
11-pointed NRS pain scoreat postoperative 24 hour11-pointed NRS pain score is measured at both resting state and movement. 11-pointed NRS pain score has minimum score of 0 and maximum score of 10, and higher score indicates the higher severity of pain.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026